Yield10 Bioscience (YTEN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

YTEN Yield10 Bioscience

Watchlist

0.525
-0.134-20.32%

15min DelayClose Nov 21 16:00 ET

0.525
0.0000.00%

Post 16:22 ET

363.66KMarket Cap-26P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Yield10 Bioscience Announces Adjournment of Special Meeting of Stockholders to Solicit Sufficient Votes in Favor of the Key Proposals
AccesswireNov 8 11:20 ET
Yield10 Bioscience Announces Asset Sale and Planned Dissolution
TipRanksOct 3 14:27 ET
Yield10 Bioscience GAAP EPS of -$5.04 Misses by $4.01
Seeking AlphaAug 15 09:53 ET
Yield10 Bioscience 2Q Loss/Shr $5.04 >YTEN
Dow JonesAug 14 16:42 ET
Express News | Yield10 Bioscience Announces Second Quarter 2024 Financial Results
ReutersAug 14 16:37 ET
Yield10 Bioscience | 10-Q: Q2 2024 Earnings Report
SECAug 14 16:06 ET · Announcements

Comments

MangoXoXo

Jul 18 04:34

$Yield10 Bioscience (YTEN.US)$ delist 5/16/24

Jaguar8

Jul 17 07:36

NEWS

$Yield10 Bioscience (YTEN.US)$
Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets
Yield10 Bioscience (OTC:YTEN) has signed a Memorandum of Understanding and License Agreement with Nuseed Nutritional US Inc., granting Nufarm a commercial license to Omega-3 assets for producing oil in Camelina. Nufarm will pay up to USD $5 million for the license. The companies have a...

Jaguar8

Jun 17 07:33

NEWS

$Yield10 Bioscience (YTEN.US)$
Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina
Yield10 Bioscience has secured an exclusive global license from Rothamsted Research to use advanced technology for producing omega-3 oils in Camelina. This agreement enables Yield10 to produce sustainable omega-3 products for aquafeed, petfood, and human nutrition markets. Supported by milestone payments and roya...